Saturday, 18 August 2018

Rutledge ELLIS-BENKE

Rutledge ELLIS-BENKE
University of Heidelberg, D - MIT - USA

 

 




 

Rutledge Ellis-Behnke is currently Scientific Advisor to Arch Therapeutics, where he is the inventing co-founder. In addition, he holds affiliate faculty positions at MIT and University of South Florida Morsani School of Medicine.

Ellis-Behnke received a PhD from MIT in Neuroscience; a Bachelor of Science from Rutgers University and graduated from Harvard Business School’s Advanced Manager’s Program (AMP).

Previously, he was the Director of the Nanomedicine Translational Think Tank at the Medical Faculty Mannheim of the University of Heidelberg in Germany. Prior to that he Associate Professor at the Faculty of Medicine at the University of Hong Kong and Associate Director of the Technology Transfer Office.

Professor Ellis-Behnke's research is focused on reconnecting the disconnected parts of the brain—with the goal of being able to provide a prescription to restore quality of life after brain or spinal cord trauma, or stroke. In animals he was the first to repair the brain showing reversal of blindness; to stop bleeding in less than 30 seconds without clotting; to preserve stem cells; and to immobilize prostate cancer stem cells. He has been granted 8 patents for his inventions.

 Back to Plenary Speakers
Back to 20 September - Afternoon

PRESENTATIONS LIST

, SCIENTIFIC PATRONAGE

 


  NANOINNOVATION'S GOT TALENT

 
call for young researchers
by BRACCO FOUNDATION

 

 

, INSTITUTIONAL PATRONAGE





  INSTITUTIONAL PARTNERS

 

    

 

  CORPORATE PARTNERS

     

 

Technical Support

Privacy

Organizing Secretariat

Dr. Cristina Gippa

+ 39 339 771 4107
+ 39 388 1785318
This email address is being protected from spambots. You need JavaScript enabled to view it.

Dr. Federica Lodato

+ 39 335 7253927
+ 39   06 8848831
This email address is being protected from spambots. You need JavaScript enabled to view it.